• Novartis AG (NVS) Makes $1.5 Billion Buy More...

• Royalty Pharma Buys an Interest in Fumaderm for $761 Million Cash More...

• Pacira Pharmaceuticals, Inc. Completes $27.5 Million Debt Refinancing More...

• Silence Therapeutics plc' Partner, Quark Pharmaceuticals Inc., Extends its Agreement With Pfizer Inc. (PFE) to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication More...

• Zealand Pharma Signs Licensing Agreement With Abbott Laboratories (ABT) for the Further Clinical Development and Commercialization of AP214 (ZP1480) for Prevention of Acute Kidney Injury More...

• Evotec AG (EVTG.F) Announces Multi-Year Agreement With The United States Environmental Protection Agency (EPA) More...

• Genomic Health, Inc. and OncoMed Pharmaceuticals, Inc. Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing More...

• Abbott Nutrition in Pact With Syngene to Open Nutrition R&D Centre More...

• FivePrime Therapeutics, Inc. Announces the Promotion ofAron Knickerbocker to Senior Vice President and Chief Business Officer More...

• Galena Biopharma (RXII) Strengthens Clinical Management Team More...

• CorMedix (CRMD) Strengthens Management Team with Addition of Randy Milby as Chief Operating Officer More...

• Covance Inc. (CVD) Announces Executive Appointments More...

• Creabilis SA Appoints Dr Simon Russell as Chief Business Officer More...

• AVI BioPharma, Inc. (AVII) Announces First Quarter 2012 Financial Results and Corporate Update Conference Call More...

• Acorda Therapeutics (ACOR) Reports First Quarter 2012 Financial Results More...

• ArQule, Inc. (ARQL) Reports First Quarter 2012 Financial Results More...

• Corcept Therapeutics Inc. (CORT) Announces First Quarter Results and Corporate and Development Update More...

• Complete Genomics, Inc. Schedules First Quarter 2012 Earnings Release and Announces Conference Call More...

• Merck & Co., Inc. (MRK) Investing $15 Million in Facility to Take on More Vaccines More...

• Linkage Biosciences Establishes New Manufacturing Facility More...

• Merck & Co., Inc. (MRK)'s Vioxx Raises Heart Risks: Studies More...

• Idera Pharmaceuticals, Inc. (IDRA)'s IMO-2055 Disappoints in Phase 2 Study More...

• Chelsea Therapeutics, Inc. (CHTP) Might Seek Limited Northera Approval, Meets With FDA This Month More...

• Genentech (RHHBY) Says SUMMACTA Study Meets Primary Endpoint More...

• Lightlake Therapeutics Inc. (LLTP) Announces Positive Preliminary Phase II Clinical Trial Results of Binge Eating Disorder Treatment More...

• Johnson & Johnson (JNJ) and Bayer HealthCare (BAY) Seek Added Use for Xarelto More...

• Hating Pork May be Genetically Determined, Duke University Study More...

• Weill Cornell Medical College Study Redefines What a Healthy Vagina is More...

• Diet Rich in Omega-3s May Lower Alzheimer's Risk, Columbia University Study More...

• Emotion Reversed in Left-Handers' Brains, The New School for Social Research Study More...

• Overdue Babies: "Risks for Those Born After 42 Weeks," Erasmus MC Study More...

• Pain Therapeutics (PTIE) Release: Four U.S. Patents Issued for REMOXY More...

• BioDiem Ltd. (BDM.AX) Release: BDM-I Patent Position Strengthened With New US Patent Relating to Malaria and Trichomoniasis More...

• Cipla Ltd. Makes Cancer Drug Cheaper More...